No abstract

No abstract

Porous scaffolds for tissue engineering applications based on poly(D,L-lactide)/poly(epsilon-caprolactone) compatibilized blends are described. The addition of a third polymer, namely poly( D, L-lactide-co-caprolactone) copolymer, has a profound effect on morphological properties of the blends scaffolds. In fact, the copolymer acts as compatibilizing agent and reduces the dimension of the dispersed phase of an order of magnitude. Such effect is function of the polymer composition. The efficiency of scaffolds obtained with poly( D, L-lactide) based blends containing 30% by weight of poly(epsilon-caprolactone) as dispersed phase toward hepatocytes has been tested by several biological assays and we found that they are able to promote a perfect adhesion, proliferation and growth of cells. Moreover, the addition of the copolymer significantly improves the biomedical performance of the scaffold.

Hydroxyapatite (Ca10(PO4)6(OH)2) is one of the most biocompatible ceramics because it is similar to the mineral constituents of human bone and teeth. Composites of hydroxyapatite (HA) and biodegradable polymers such as polycaprolactone (PCL) are interesting materials for medical applications, especially for bone replacement. With the aim to improve the properties of biodegradable polyester-based devices, we have prepared and characterized novel composites made of polycaprolactone and natural or synthetic hydroxyapatite. The composites were screened for cytocompatibility by a direct contact method, in view of the future application of these hydroxyapatite filled PCL polymers as scaffolds for bone engineering. Primary cultures of human bone marrow mesenchymal stem cells (MSC) were selected as the most appropriate models to study the in vitro performance of these materials.

In the present article, several developments of biocomposites containing silica nanoparticles intended for bone regeneration are reported. Nanocomposites of poly(ε-caprolactone) (PCL) and silica, in which either the silica nanoparticles or the PCL have been modified in order to improve interfacial adhesion through chemical graft between the phases are hereafter described. The composites are characterized with respect to their chemical-physical and mechanical properties. Their biocompatibility and capacity to induce the osteoblastic phenotype in human bone marrow mesenchymal stem cells have been assessed.